Replies to post #7984 on Aurinia Pharmaceuticals Inc (AUPH)

[northern vortex]

I agree with all that you say.

Furthermore, if I heard correctly, Dr. Glickman stated that AUPH would be testing different dosages in order to improve tolerability while retaining efficacy.

They need to win on both the comfort and efficacy fronts in order for a chance to elevate the product to blockbuster status.